Niemann-Pick Diseases: Clinical Trials

15 trials for Niemann-Pick Diseases, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

10 completed, 3 terminated, 1 recruiting, 1 unknown. 15 Phase 1, 8 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 115Completed 10, Terminated 3, Recruiting 1, Unknown 1
Phase 28Completed 6, Terminated 2

Follow Niemann-Pick Diseases: new trials by email Literature Review of Niemann-Pick Diseases trials Research Report on Niemann-Pick Diseases

Trials (filtered) newest first · largest first

All 15 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Combined Intrathecal and Intravenous VTS-270 Therapy for Liver and Neurological Disease Associated With Niemann-Pick Disease, Type C1
VTS-270 - Niemann-Pick Disease, Type C1
Phase 1 / Phase 2TerminatedEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)22020-01-062022-08-30
Open-Label Study of Long-Term Safety and Efficacy of Intravenous Trappsol Cyclo (HPβCD) in Niemann-Pick Disease Type C
Hydroxypropyl-β-cyclodextrin - Niemann-Pick Disease, Type C1
Phase 1UnknownCyclo Therapeutics, Inc.122019-05-232021-06-18
Study of IV VTS-270 for Infantile Liver Disease Associated With Niemann-Pick Disease, Type C
VTS-270 - Niemann-Pick Disease, Type C
Phase 1 / Phase 2CompletedWashington University School of Medicine42019-02-222026-01-05
Study of the Pharmacokinetics of Trappsol and Effects on Potential Biomarkers of Niemann-Pick C1 (NPC1)
Hydroxypropyl-beta-cyclodextrin - Niemann-Pick Disease, Type C1
Phase 1CompletedCyclo Therapeutics, Inc.132017-10-112021-02-21
Safety and Efficacy of Intravenous Trappsol Cyclo (HPBCD) in Niemann-Pick Type C Patients
Hydroxypropyl-beta-cyclodextrin - Niemann-Pick Disease, Type C1
Phase 1 / Phase 2CompletedCyclo Therapeutics, Inc.122017-03-202021-08-10
Safety, Tolerability, PK, and Efficacy Evaluation of Repeat Ascending Doses of Olipudase Alfa in Pediatric Patients <18 Years of Age With Acid Sphingomyelinase Deficiency
Olipudase alfa - Sphingomyelin Lipidosis
Phase 1 / Phase 2CompletedGenzyme, a Sanofi Company202015-05-012022-03-23
UCB Transplant of Inherited Metabolic Diseases With Administration of Intrathecal UCB Derived Oligodendrocyte-Like Cells
DUOC-01 - Adrenoleukodystrophy, Batten Disease
Phase 1RecruitingJoanne Kurtzberg, MD402014-09-012026-09-03
Phase 1/2 Study of Vorinostat Therapy in Niemann-Pick Disease, Type C1
Vorinostat - Neimann-Pick Disease
Phase 1 / Phase 2CompletedEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)122014-04-252018-02-22
Human Placental-Derived Stem Cell Transplantation
Human Placental Derived Stem Cell - Mucopolysaccharidosis I, Mucopolysaccharidosis VI
Phase 1CompletedNew York Medical College432013-04-012022-10-25
Hydroxypropyl Beta Cyclodextrin for Niemann-Pick Type C1 Disease
VTS-270 - Niemann-Pick Disease, Type C1
Phase 1CompletedVtesse, LLC, a Mallinckrodt Pharmaceuticals Company142013-01-012021-07-23
Phase I/II Pilot Study of Mixed Chimerism to Treat Inherited Metabolic Disorders
hematopoietic stem cell infusion - Hurler Syndrome (MPS I), Hurler-Scheie Syndrome
Phase 1 / Phase 2TerminatedTalaris Therapeutics Inc.32011-04-012023-04-12
Biomarker Validation for Niemann-Pick Disease, Type C: Safety and Efficacy of N-Acetyl Cysteine
N-Acetyl Cysteine - Niemann-Pick Disease, Type C
Phase 1 / Phase 2CompletedEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)352009-08-012013-05-06
Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells
Hematopoietic stem cell transplantation - Sickle Cell Disease, Thalassemia
Phase 1 / Phase 2CompletedChildren's Hospital Los Angeles252008-08-012016-06-23
Safety Study of rhASM Enzyme Replacement Therapy in Adults With Acid Sphingomyelinase Deficiency (Niemann-Pick Disease)
rhASM - Acid Sphingomyelinase Deficiency, Niemann-Pick Disease
Phase 1TerminatedGenzyme, a Sanofi Company112006-12-012015-03-19
Saccadic Eye Movements in Patients With Niemann-Pick Type C Disease
OGT918 - Niemann Pick Diseases
Phase 1CompletedNational Eye Institute (NEI)302002-10-172017-07-02

Narrower conditions

Niemann-Pick Disease, Type C (8)  ·  Adrenoleukodystrophy (3)  ·  Leukodystrophy, Globoid Cell (3)  ·  Leukodystrophy, Metachromatic (3)  ·  Mucopolysaccharidosis I (3)  ·  Niemann-Pick Disease, Type A (3)  ·  Fucosidosis (2)  ·  Mucopolysaccharidosis II (2)  ·  Nerve Degeneration (2)  ·  Neuronal Ceroid-Lipofuscinoses (2)  ·  Sandhoff Disease (2)  ·  Tay-Sachs Disease (2)  ·  alpha-Mannosidosis (2)  ·  Anemia (1)

Broader conditions

Brain Diseases (15)  ·  Brain Diseases, Metabolic (15)  ·  Central Nervous System Diseases (15)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (15)  ·  Hemic and Lymphatic Diseases (15)  ·  Histiocytosis (15)  ·  Histiocytosis, Non-Langerhans-Cell (15)  ·  Lipid Metabolism Disorders (15)  ·  Lipid Metabolism, Inborn Errors (15)  ·  Lipidoses (15)  ·  Lymphatic Diseases (15)  ·  Lysosomal Storage Diseases, Nervous System (15)  ·  Metabolic Diseases (15)  ·  Nervous System Diseases (15)  ·  Nutritional and Metabolic Diseases (15)

Interventions

2-Hydroxypropyl-beta-cyclodextrin (4)  ·  Acetylcysteine (1)  ·  Hematopoietic Stem Cell Transplantation (1)  ·  Stem Cell Transplantation (1)  ·  Vorinostat (1)  ·  miglustat (1)  ·  olipudase alfa (1)

Sponsors

Cyclo Therapeutics, Inc. (3)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (3)  ·  Genzyme, a Sanofi Company (2)  ·  Children's Hospital Los Angeles (1)  ·  Joanne Kurtzberg, MD (1)  ·  National Eye Institute (NEI) (1)  ·  New York Medical College (1)  ·  Talaris Therapeutics Inc. (1)  ·  Vtesse, LLC, a Mallinckrodt Pharmaceuticals Company (1)  ·  Washington University School of Medicine (1)

Countries

United States (14)  ·  United Kingdom (3)  ·  Brazil (1)  ·  France (1)  ·  Germany (1)  ·  Israel (1)  ·  Italy (1)  ·  Sweden (1)

Top investigators

Forbes D Porter, M.D. (3)  ·  Caroline Hastings, MD (2)  ·  Hisham Abdel-Azim, MD (1)  ·  Joanne Kurtzberg, MD (1)  ·  Mitchell S Cairo, MD (1)  ·  Patricia I Dickson, MD (1)  ·  Reena Sharma, MB BS (1)  ·  Suzanne T Ildstad, MD (1)

Results publications

PMID 36279795, PMID 31187454, PMID 33875845, PMID 34389161, PMID 34810067, PMID 37670901, PMID 40525490

NIH funding

U01HD090845 (1)